Navigation Links
US-Based Bollywood On-Demand Service to Sponsor 'Faces of India' YouthAIDS Gala on November 2nd
Date:10/12/2007

rs Weir. Adding, "We believe this strongly in the cause and the tireless work of YouthAIDS. If our board and investors can adopt this incremental risk to our market outcomes and, by so doing, reduce the risk of HIV/AIDS, it's a compelling and obliging trade we welcome. We only hope those with the ability to mitigate these health and human tragedy risks at greater scale take note of the example, and act even more boldly."

Speaking of the decision to sponsor the event, Tinsel board director and investor and, Chairman of Innovative Energy Group, Muhammad Rafique, said, "Our investments are naturally profit-driven, but our hearts and our resources are always behind such honorable causes. While some might consider it early for TinselVision(TM) to be taking on significant community involvements, we elected without hesitation to support the chairman's request to support this event and YouthAIDS on a continuing basis."

The YouthAids Gala 2007 is themed, Faces of India, with an emphasis on Hollywood Meets Bollywood. Shelia C. Johnson and Honorable William T. Newman, Vicki and Roger Sant and Sudhakar Shenoy are the Gala Chairs this year.

Ashley Judd will be joined by honored guest, Bono, along with performances by Michael McDonald, Russell Peters and DJ Rekha. Special guests include Miss India Puja Gupta and Emmy Rossum, with an opening message from His Holiness Sri Sri Ravi Shankar.

About TinselVision

TinselVision(TM), a trademarked service of Tinsel Cinema, LLC, is a Washington, DC and Mumbai, India-based premium VoD provider scheduled to launch its niche service in October, 2007. TinselVision will deliver Bollywood and South Asian movies, television series and sporting events via IPTV to PCs, laptops, TVs and mobile devices to South Asian households in the US, UK, Canada, and globally. The service seeks to provide nearly 10 million viewers with choice, affordability, control and convenience through on-demand access to one of the largest librar
'/>"/>

SOURCE TinselVision
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Apollos Global Arm Acquires US-based Firm
2. Promote Health Tourism, Say US-Based Malayalis
3. Medicos Plan Anti-Quota Stir In Mumbai; Bollywood To Join Up
4. Australian beauty with roots in India open to acting in Bollywood
5. Gere Jives To Bollywood Songs To Spread AIDS Awareness
6. Male Casting Couch in Bollywood?
7. Support Services found to Dramatically Impact Pediatric Health Care
8. Mental Health Services for Children
9. London Emergency Services Receive Wide Appreciation
10. Health and Human Services stockpiles 20 million bird flu Vaccines
11. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)..., COLLEGE PARK, MD. - A long history of terrori...s in Mumbai. The Global Terrorism Database (GTD), ...tional Consortium for the Study of Terrorism and R...00 terrorist attacks in India since 1970. Fataliti...eely available online. , The GTD is the most com...
(Date:12/2/2008)...ASHINGTON, Dec. 2 EIN N...te providing in-depth news on lung cancer. , ,...atients are finding out that information is one of..., Responding to the growing demand for accurate ...creening procedures and drugs to treat it, EIN New...
(Date:12/2/2008)..., , ROCKVILLE, Md., Dec. 2 /PRNewswire-USNe...ed sleep periods and increased supervision of work...ining environment, according to a new Institute of...are Research and Quality. , , The report i...ee that reviewed the relationship between resident...
(Date:12/2/2008)...OCHESTER, N.Y., Dec. 2 V...provider of quantitative imaging for clinical,tri...ceeds $27 million,compared to $14.7 million at th...se. The company calculates backlog as the amount r... contracts. The duration of the studies,included ...
Breaking Medicine News(10 mins):Health News:India terrorism by the numbers 2Health News:EIN News Introduces 'Lung Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3
...mount Americans spent on arthritis medications mor...ast-rising number of people// with the disease, in...h month and the inflation-adjusted cost per prescr...by a UCSF researcher. Results from a six-year stu...
...ebate on abortion is polarizing the US. Striking a...Spitzer has said that he would introduce// a bill ...week a conservative-dominated Supreme Court upheld...Ban Act, signed by President Bush in 2003. The ban...
...esponsibility and resources for public health and ...al councils rather than with the NHS, argues an ex...f Durham University says that partnerships between...HS would then become a true meeting of the two sid...
...tists at the Lundberg Laboratory for Cancer Resear...cademy in Sweden have discovered a //new hereditar...red that women possessing a certain hereditary def...k , almost twenty times, of contracting breast can...
Other Medicine News:Health News:Treatment Cost for Arthritis on the Rise: Study 2Health News:New York Governor to Introduce Bill to Strengthen Abortion Rights 2Health News:Local Councils Should Be Responsible for Tackling Health Inequalities 2Health News:Gene Behind Breast Cancer Found 2
(Date:12/1/2008)... SINGAPORE, Dec. 1 S*BIO Pte Ltd ...ical trial of SB1518, a potent and orally-active J...alia for patients with chronic idiopathic myelofib... evaluate the safety and tolerability of SB1518 in... 50 patients. The Phase 1 part of the study will ...
(Date:12/1/2008)... Baby Girl with Hypophosphatasia Treated With ENB...re in Winnipeg , , MONTREAL, Dec. 1 /PRNews...ch company focused on developing novel therapeutic... the first infant patient in its clinical program ...ating Enzyme Replacement Therapy (ERT) with ENB-00...
(Date:12/1/2008)... , Abstinence is still the best policy , ...ire/ -- A new study from Mayo Clinic finds the use...ating alcoholic hepatitis, an acute inflammation o...ohol. The results of the study are published in th...w.gastrojournal.org/ ). , , VIDEO ALERT: A...
(Date:12/1/2008)... KVISTGARD, Denmark, December 1 /PRNewswire-F...ued in 2007 with the intent to procure an MVA-base...s and Government Services,Canada, on behalf of th...rded,a contract to Bavarian Nordic for the delive...es intend to use IMVAMUNE(R) as part of the,count...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 1BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2100 3Anesiva Announces May 22 2008 Presentation at Citi Investment Research Global HealthCare Conference 19576 1New Gene Methylation Test for Prostate Cancer Available 2096 1Jazz Pharmaceuticals to Present at Investor Conferences 19573 1
...(MARKET WIRE) -- July 02, 2007 -- DOR BioPharma, I...ed today that the,first results from testing of a ...T-VACC™, have been published in the journal,... Infection and,Immunity, v. 75, p. 3043 ). These r...immunity elicited by a multivalent vaccine,that is...
... Update to Timeline for Second Pivotal Phase 3 Tri...Call/ -- Advanced Life,Sciences Holdings, Inc. , t...ficacy data from Trial CL-06, the first of two,piv...e safety and,effectiveness of cethromycin, a novel...nity acquired pneumonia (CAP). The Company,also pr...
Other Medicine Technology:DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),
Steroid-eluting, screw-in pacing lead
Tendril SDX is one of the world's thinnest, extendable/retractable pacing leads. Implantable with a 7 F introducer, the lead's reduced body diameter is designed to lower the incidence of venous obstr
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase.
Medicine Products: